Pacer Advisors, Inc. Amicus Therapeutics, Inc. Transaction History

Pacer Advisors, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$9.04 - $11.75 $7,873 - $10,234	-871 Reduced 25.12%	2,597 $25,000
Q1 2024 May 10, 2024	BUY	$11.43 - $14.24 $39,639 - $49,384	3,468 New	3,468 $40,000
Q2 2021 Jul 21, 2021	SELL	$8.71 - $10.72 $63,042 - $77,591	-7,238 Closed	0 $0
Q1 2021 Apr 05, 2021	BUY	$9.2 - $23.86 $11,518 - $29,872	1,252 Added 20.92%	7,238 $72,000
Q4 2020 Jan 20, 2021	SELL	$13.47 - $24.89 $48,923 - $90,400	-3,632 Reduced 37.76%	5,986 $138,000
Q3 2020 Oct 19, 2020	BUY	$12.89 - $15.89 $123,976 - $152,830	9,618 New	9,618 $136,000
Q4 2018 Feb 13, 2019	SELL	$8.38 - $13.44 $174,387 - $279,686	-20,810 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$11.6 - $16.54 $241,396 - $344,197	20,810 New	20,810 $252,000
Q1 2018 May 14, 2018	SELL	$13.76 - $17.12 $103,200 - $128,400	-7,500 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$12.51 - $16.24 $93,825 - $121,799	7,500	7,500 $108,000

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.